Seung Il Jung
Papers
1
Total Citations
21
H-Index
1
About
Dr. Seung Il Jung is a leading urologic oncology researcher whose work centers on health-related quality of life (HRQOL) outcomes in prostate cancer patients, particularly following radical prostatectomy. His most-cited study, a longitudinal cohort investigation published in 2018, systematically compared HRQOL changes across open, laparoscopic, and robotic surgical approaches, providing critical evidence to guide treatment decision-making. This work has accumulated 21 citations, reflecting its value in an era where patient-reported outcomes are increasingly central to cancer care. Dr. Jung’s contributions help bridge the gap between surgical efficacy and patient experience, empowering men to make more informed choices about their treatment. His research underscores a commitment to personalized medicine, emphasizing that survival statistics alone are insufficient without understanding how interventions affect daily living. By focusing on the nuanced recovery trajectories after different prostatectomy techniques, Dr. Jung has advanced the field’s understanding of postoperative well-being, making him a respected voice in urologic oncology and patient-centered outcomes research.
Research Focus
Key Achievements
Top Papers
- 1